MXPA03006359A - Metodo para tratamiento del cancer. - Google Patents
Metodo para tratamiento del cancer.Info
- Publication number
- MXPA03006359A MXPA03006359A MXPA03006359A MXPA03006359A MXPA03006359A MX PA03006359 A MXPA03006359 A MX PA03006359A MX PA03006359 A MXPA03006359 A MX PA03006359A MX PA03006359 A MXPA03006359 A MX PA03006359A MX PA03006359 A MXPA03006359 A MX PA03006359A
- Authority
- MX
- Mexico
- Prior art keywords
- adverse effects
- treating cancer
- greater efficacy
- reduced adverse
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Se describe un metodo para el tratamiento de pacientes con cancer que involucra la administracion de una combinacion de regimen de un agente de platino, un agente taxano, y un agente de reduccion de toxicidad de la formula I. El orden preferido de administracion es el compuesto de la formula (I), seguido por el complejo de platino, seguido por el agente taxano.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26312701P | 2001-01-19 | 2001-01-19 | |
PCT/US2002/000943 WO2002056755A2 (en) | 2001-01-19 | 2002-01-11 | Method for treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03006359A true MXPA03006359A (es) | 2004-04-20 |
Family
ID=23000486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03006359A MXPA03006359A (es) | 2001-01-19 | 2002-01-11 | Metodo para tratamiento del cancer. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1351677A4 (es) |
JP (2) | JP2004523518A (es) |
AU (1) | AU2002251763B2 (es) |
CA (1) | CA2434270A1 (es) |
MX (1) | MXPA03006359A (es) |
WO (1) | WO2002056755A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8710095B2 (en) | 2002-04-30 | 2014-04-29 | Bionumerik Pharmaceuticals, Inc. | Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity |
CA3054535A1 (en) | 2005-02-18 | 2006-08-24 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
CA2718233A1 (en) * | 2008-03-14 | 2009-09-17 | Bionumerik Pharmaceuticals, Inc. | Compositions and methods of use of compounds to increase cancer patient survival time |
ES2476602T3 (es) * | 2008-03-14 | 2014-07-15 | Bionumerik Pharmaceuticals, Inc. | Composiciones y métodos quimioprotectores |
DK2249825T3 (en) * | 2008-03-14 | 2016-01-11 | Bionumerik Pharmaceuticals Inc | Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5919816A (en) * | 1994-11-14 | 1999-07-06 | Bionumerik Pharmaceuticals, Inc. | Formulations and methods of reducing toxicity of antineoplastic agents |
US5789000A (en) * | 1994-11-14 | 1998-08-04 | Bionumerik Pharmaceuticals, Inc. | Sterile aqueous parenteral formulations of cis-diammine dichloro platinum |
PT957920E (pt) * | 1996-09-23 | 2002-06-28 | Bionumerik Pharmaceuticals Inc | Reducao dos efeitos toxicos de carboplatina utilizando ditioeteres |
-
2002
- 2002-01-11 WO PCT/US2002/000943 patent/WO2002056755A2/en active Application Filing
- 2002-01-11 AU AU2002251763A patent/AU2002251763B2/en not_active Ceased
- 2002-01-11 EP EP02720788A patent/EP1351677A4/en not_active Withdrawn
- 2002-01-11 MX MXPA03006359A patent/MXPA03006359A/es active IP Right Grant
- 2002-01-11 CA CA002434270A patent/CA2434270A1/en not_active Abandoned
- 2002-01-11 JP JP2002557269A patent/JP2004523518A/ja active Pending
-
2009
- 2009-09-14 JP JP2009212441A patent/JP2009292837A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1351677A4 (en) | 2009-08-19 |
EP1351677A2 (en) | 2003-10-15 |
JP2004523518A (ja) | 2004-08-05 |
WO2002056755A3 (en) | 2002-09-26 |
AU2002251763B2 (en) | 2006-05-04 |
JP2009292837A (ja) | 2009-12-17 |
CA2434270A1 (en) | 2002-07-25 |
WO2002056755A2 (en) | 2002-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
MXPA03008623A (es) | Combinacion farmaceutica para el tratamiento del cancer. | |
DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
EG25822A (en) | Quinolinyl-pyrrolopyrazoles | |
TNSN04065A1 (en) | Treatment of acute myeloid leukemia with indolinone compounds | |
BRPI0413746A (pt) | composto ou um seu n-óxido ou seu sal farmaceuticamente aceitável, composição, e, método de tratamento de distúrbio hiperproliferativo | |
WO2001066103A3 (en) | Treatment of neoplasms by inhalation of carboplatin | |
MXPA03007140A (es) | Derivados de carbolina. | |
BR0207316A (pt) | Derivados de epotilona para o tratamento de tumores refratários | |
WO2003024391A3 (en) | Treatment and prevention of mucositis in cancer patients | |
DE60205899D1 (en) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
WO2004110151A8 (en) | Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments | |
IL165259A0 (en) | Compounds useful in the treatment of anthraxa and inhibiting lethal factor | |
AU2003300385A8 (en) | Anticancer compounds | |
MXPA03006359A (es) | Metodo para tratamiento del cancer. | |
WO2004007676A3 (en) | Combination therapy for the treatment of neoplasms | |
AU3919001A (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers | |
PL1648473T3 (pl) | Pojedyncza dawka szybko rozpuszczającej się azytromycyny | |
WO2002078690A3 (en) | Taxoid anti-tumor agents and pharmaceutical compositions thereof | |
WO2003026581A3 (en) | Pharmaceutical compositions and methods for treating cancer | |
MXPA05006722A (es) | Metodo para tratamiento de pacientes con exposicion a radiacion. | |
TR200201192T1 (tr) | Kanser terapi maddelerinin kuvvetlendirilmesine yönelik metod ve terkipler | |
WO2002094183A3 (en) | A method for tumor treatment with fumagillol derivatives | |
EP1512413A3 (en) | Pharmaceutical combination containing a 4-quinazolineamine and another anti-neoplastic agent for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |